| PCNSL | Primary central nervous system lymphoma |
| MRI | Magnetic resonance imaging |
| PFS | Progression-free survival |
| OS | Overall survival |
| HD-MTX | High-dose methotrexate |
| WBRT | Whole-brain radiotherapy |
| IELSG | International Extranodal Lymphoma Study Group |
| MSKCC | Memorial Sloan-Kettering Cancer Center |
| CSF | Cerebrospinal fluid |
| DLBCL | Diffuse large B-cell lymphoma |
| KPS | Karnofsky Performance Status |
| ECOG | Eastern Cooperative Oncology Group |
| LDH | Lactate dehydrogenase |
| HR | Hazard ratio |
| CI | Confidence interval |
| CR | Complete response |
| PR | Partial response |
| SD | Stable disease |
| PD | Progressive disease |
| ORR | Overall response rate |
| RT | Radiotherapy |